InfuSystem (NYSE:INFU) Director Paul Andrew Gendron Buys 5,000 Shares

InfuSystem Holdings, Inc. (NYSE:INFU) Director Paul Andrew Gendron bought 5,000 shares of the stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $8.88 per share, with a total value of $44,400.00. Following the completion of the transaction, the director directly owned 70,000 shares in the company, valued at approximately $621,600. The trade was a 7.69% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

InfuSystem Stock Performance

Shares of NYSE:INFU opened at $8.41 on Wednesday. The firm has a fifty day simple moving average of $9.67 and a two-hundred day simple moving average of $9.20. InfuSystem Holdings, Inc. has a 52 week low of $5.08 and a 52 week high of $11.04. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $169.83 million, a P/E ratio of 140.19 and a beta of 1.49.

Analyst Ratings Changes

Separately, Roth Mkm reiterated a “buy” rating and issued a $15.00 price target (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.00.

Institutional Trading of InfuSystem

Several institutional investors and hedge funds have recently added to or reduced their stakes in INFU. Hillsdale Investment Management Inc. acquired a new position in shares of InfuSystem in the 3rd quarter valued at $4,665,000. Arrowstreet Capital Limited Partnership increased its holdings in InfuSystem by 220.1% during the third quarter. Arrowstreet Capital Limited Partnership now owns 449,348 shares of the company’s stock worth $4,655,000 after buying an additional 308,974 shares during the last quarter. Ancora Advisors LLC acquired a new position in shares of InfuSystem during the 3rd quarter worth about $2,096,000. Teton Advisors LLC acquired a new position in InfuSystem during the third quarter worth approximately $1,917,000. Finally, Jane Street Group LLC raised its stake in InfuSystem by 943.1% in the 2nd quarter. Jane Street Group LLC now owns 186,159 shares of the company’s stock valued at $1,162,000 after acquiring an additional 168,312 shares during the period. 71.13% of the stock is owned by institutional investors.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.